Indian CRAMS Industry - For Indian Customers Market Reports on India presents the report on "Indian CRAMS Industry - For Indian Customers" the global CRAMS industry scenario and analyses the major players, and competition. Feb 23, 2015 – Navi Mumbai, India: Market Reports on India presents the report on " Indian CRAMS Industry - For Indian Customers"the area of drug development and research chemistry with large number of pharmacists and chemistry post graduates qualifying every year. Summary : The Indian Contract Research and Manufacturing Services (CRAMS) industry is estimated to be worth ~US$6.6bn in CY2012. CRAMS industry has two main segments – Contract Manufacturing Services (CMS), which accounts for more than 60% of the industry; and Contract Research Services (CRS), which accounts for the rest. CMS is expected to dominate the industry in the foreseeable future. CARE Research expects the domestic CRAMS industry to grow at robust rate from CY2013-2017. Companies in the Indian CRAMS industry are benefitted by lower manufacturing costs, rising cost of research in developed markets and increase in number of drugs going off-patent. These conditions are leading to an increase in outsourcing of pharmaceutical manufacture and research. Indian companies are increasingly being preferred due to their product mix catering to high-end research services, biologics and complex technology services. Also, India offers a significant pool of professionals in the area of drug development and research chemistry with large number of pharmacists and chemistry post graduates qualifying every year. The report on ‘Indian CRAMS Industry’ evaluates the industry scenario and presents its outlook based on past performance and the evolving dynamic in the industry. It also focuses on growth opportunities, growth drivers, player analysis, and regulatory scenario. The report highlights various supportive measures taken by the government, that have helped the sector perform well. The report also describes the global CRAMS industry scenario and analyses the major players, and competition. The report explains the challenges and risks faced by the industry players. The informative report is comprehensive and indispensable for any company in CRAMS industry, pharmaceuticals business, banks/ FIs, policy makers, research & academic organizations, other international and national agencies, etc. Additionally, the quarterly updates (for the period Q1FY14 to Q4FY14) accompanying the subscription of the said report would form a potent tool for the subscribers to keep abreast of the happenings in the industry. Table of Content: SECTION- I CARE Research’s OUTLOOK Outlook Outlook on the Indian CRAMS Industry SECTION- II INDUSTRY SECTION Overview of Indian Pharmaceutical Industry Major market segments Market size